Clinical Trials on Refractory Neoplasms in Switzerland

Total 2027 results

University of Zurich
University Hospital Inselspital, Berne; Swiss Paraplegic Centre Nottwil; Cantonal...

Completed

Sacral Neuromodulation for Neurogenic LUT Dysfunction

Refractory Neurogenic LUTD

Switzerland
Cristiana Sessa

Completed

Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphoma (IOSI-LND-001)

B-cell Lymphoma Refractory

Switzerland
University Hospital, Basel, Switzerland

Completed

Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction (RESET)

Status Epilepticus | Refractory Status Epilepticus

Switzerland
University Hospital, Basel, Switzerland

Withdrawn

Compare the Efficacy and Safety of Intranasal Esketamine in Chronic Opioid Refractory Pain (IMPORTANCE)

Cancer Pain

Switzerland
Janssen Research & Development, LLC

Approved for marketing

Pre-Approval Access Program for Talquetamab in Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

Brazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
Gustave Roussy, Cancer Campus, Grand Paris
Innovative Therapies For Children with Cancer Consortium

Terminated

Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults (VINILO)

Refractory Low-grade Gliomas | Recurrent Low-grade Gliomas

Austria, Italy, France, Denmark, Netherlands, Spain, Switzerland, United Kingdom
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults (VINILO)

Refractory Low-grade Gliomas | Recurrent Low-grade Gliomas

Austria, Italy, France, Denmark, Netherlands, Spain, Switzerland, United Kingdom
Balgrist University Hospital
University of Bern

Terminated

National Swiss Sarcoma Cohort Study (SwissSARCOS)

Sarcoma | Neoplasms | Soft Tissue Sarcoma | Neoplasm of Bone | Soft Tissue Neoplasm | Sarcoma of Bone

Switzerland
University Hospital Inselspital, Berne
University of Bern

Terminated

Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections

Liver Neoplasm

Switzerland
University Hospital, Geneva

Completed

Human Papillomavirus (HPV) Self-sampling as a Test of Cure After Treatment of Cervical Intra-epithelial Neoplasia

Cervical Intra-epithelial Neoplasia Grade 1 or Worse

Switzerland
Novartis Pharmaceuticals

Completed

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

Advanced Solid Tumors | Recurrent or Refractory Medulloblastoma | Locally Advanced or Metastatic Basal Cell Carcinoma

United States, United Kingdom, Switzerland, Netherlands
University of Zurich

Unknown

Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis

Breast Cancer | Metastatic Neoplasm | ERBB2

Switzerland
University Hospital, Geneva

Active, not recruiting

FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer

Breast Neoplasm

Switzerland
University of Zurich

Unknown

Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM) (ALPPSforCRLM)

Liver Diseases | Liver Neoplasms | Hepatectomy | Surgery | Secondary Malignant Neoplasm of Liver | Colon Cancer Liver Metastases | Malignant Neoplasm of Large Intestine Metastatic to Liver

Switzerland
University of Zurich
Centre Hospitalier Universitaire Vaudois

Terminated

Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization

Liver Neoplasm

Switzerland
Onconova Therapeutics, Inc.

Terminated

Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA (INSPIRE)

Myelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEB

United States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
University of Zurich

Completed

Impact of Preoperative Chemotherapy on Complications and Regeneration After Resection of Colorectal Liver Metastases

Colorectal Liver Metastases

Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma (OptiPOM)

Refractory Multiple Myeloma

Switzerland
University of Bern

Completed

Impact of Microparticles on Postoperative Complications in Surgical Patients

Colorectal Neoplasms | Pancreatic Neoplasms | Neoplasm, Hepatic

Switzerland
Prof. Dr. med. Dres. h.c. Jan Schmidt, MME

Recruiting

Patient-derived Organoids Drug Screen in Pancreatic Cancer

Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreas Adenocarcinoma | Pancreas Cancer | Pancreas Neoplasm

Switzerland
St.Gallen University of Applied Sciences
Medical University of Vienna; University Hospital Inselspital, Berne; University... and other collaborators

Completed

The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence (WOMAN-PROII)

Vulvar Cancer | Vulvar Intraepithelial Neoplasia

Switzerland
Daniel Stephan Engeler

Completed

Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors

Neoplasm of Lateral Wall of Urinary Bladder

Switzerland
Cantonal Hospital of St. Gallen
University Hospital, Geneva; University Hospital Muenster; Stanford University; University of Toronto and other collaborators

Recruiting

Microsurgical Resection of Intramedullary Spinal Cord Metastases

Spinal Cord Neoplasms | Radiotherapy; Complications | Functional Outcome | Spinal Cord Metastasis | Spinal Cord Tumor Malignant Intramedullary

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial (LUMEN1)

MEN1 Gene Mutation

Switzerland
Kite, A Gilead Company

Recruiting

Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies (ZUMA-25)

Relapsed/Refractory Waldenstrom Macroglobulinemia | Relapsed/Refractory Richter Transformation | Relapsed/Refractory Burkitt Lymphoma | Relapsed/Refractory Hairy Cell Leukemia

United States, Spain, Germany, Italy, France, Netherlands, Switzerland, Austria
Kantonsspital Graubuenden
Swiss Group for Clinical Cancer Research

Completed

SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience

Prostate Cancer | Prostate Cancer Recurrent | Lymph Node Metastases

Switzerland
University Hospital Inselspital, Berne
Swiss National Science Foundation

Completed

USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases

Prostate Cancer | Bladder Cancer

Switzerland
Matthias Guckenberger

Recruiting

Single-isocenter SBRT vs. Multiple-isocenter SBRT for Multiple Extracranial Metastases

Metastatic Cancer

Switzerland
Anaveon AG

Terminated

A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)

Hematologic Diseases | Multiple Myeloma | Refractory Multiple Myeloma | Adult Disease | Relapsed Cancer

Spain, Germany, France, Denmark, Switzerland
Valentina Garibotto
University Hospital, Geneva

Completed

18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.

Prostate Cancer | Bone Metastases

Switzerland
University Hospital, Basel, Switzerland

Completed

DOTA-TOC in Metastasized Neuroendocrine Tumors

Neuroendocrine Tumors

Switzerland
Aurelius Omlin
University Hospital, Zürich; Teva Pharma

Terminated

Carboplatin in Castration-resistant Prostate Cancer (PRO-PLAT)

Prostatic Neoplasm

Switzerland
University of Zurich

Active, not recruiting

Clinical Trial Comparing Dose-intensified SBRT With Conventional Radiation Therapy for Spinal Metastases (DOSIS RCT)

Spinal Metastasis

Switzerland
Andreas Arnold

Completed

EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients (EBVER/TMC)

Immunosuppression | Neoplasm

Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL

Leukemia | Chronic Lymphocytic Leukemia | Relapsed/Refractory Chronic Lymphocytic Leukemia

Switzerland
Manuela Eicher
Swiss Cancer League; Lindenhofgruppe AG

Completed

Testing of the Cancer Thriving and Surviving Breast Cancer Program (COSS)

Breast Neoplasm | Self-Management | Intervention | Cancer Survivorship | Early-Stage Breast Cancer

Switzerland
University of Zurich

Completed

Anesthesia and Circulating Tumor Cells in Breast Cancer

Female Breast Carcinoma

Switzerland
Bristol-Myers Squibb

Recruiting

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Relapsed/Refractory Non-Hodgkin Lymphoma

United States, Spain, France, Netherlands, Switzerland
Oncology Institute of Southern Switzerland

Recruiting

Liquid Biopsy in Mature B-cell Tumors

Mature B-Cell Neoplasm

Switzerland
Centre Hospitalier Universitaire Vaudois

Recruiting

Irradiation of Melanoma in a Pulse (IMPulse)

Metastasis From Malignant Melanoma of Skin (Diagnosis)

Switzerland
Thomas Steffen
Gottfried und Julia Bangerter-Rhyner Foundation, Switzerland

Terminated

Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy? (CaCo)

Colorectal Neoplasm | Diverticulitis | Postoperative Ileus | Laparoscopic Colectomy Without Stoma Formation

Switzerland
Sana Boudabbous

Recruiting

Pain Relief in Symptomatic Bone Metastases With Adjuvant Hyperthermia MR Guided HIFU (BM-RT-HIFU)

MRI | Pain | Bone Metastases | Radiotherapy

Switzerland
Centre Hospitalier Universitaire Vaudois

Unknown

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

Colorectal Cancer | Metastatic Cancer

Switzerland
University of Zurich
Leiden University Medical Center

Active, not recruiting

Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"

Squamous Cell Carcinoma

Netherlands, Switzerland
University Hospital, Basel, Switzerland

Recruiting

Circulating Tumor Cells (CTC) in Cancer

Cancer

Switzerland
Sequana Medical N.V.

Completed

ALFApump System Post Marketing Surveillance Registry (2011-AAR-004)

Liver Cirrhosis | Malignant Ascites | Refractory Ascites

Germany, Switzerland, Spain, United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)

Acute Myelogenous Leukemia | Refractory Leukemia

Belgium, Korea, Republic of, Turkey, Germany, Australia, France, Switzerland, United Kingdom, Spain, Italy, Peru, United States
Walter Brunner

Completed

Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision (RLF)

Rectal Neoplasms

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Longterm Functional Outcomes in Patients Undergoing Organ Preserving Treatment for Rectal Cancer With or Without Local Excision After Chemoradiotherapy (PRESERVE)

Rectal Cancer

Switzerland
University Hospital Inselspital, Berne

Active, not recruiting

Intratumoral Budding (ITB) in Preoperative Biopsies of Colon and Rectal Cancer (ITB)

CRC

Switzerland

Clinical Trials on Refractory Neoplasms in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations